VEDOKIDS study: Predicting response to Vedolizumab in Pediatric Inflammatory Bowel Diseases including drug levels: a multi-center prospective Pan- European cohort study (P-ECCO and ESPGHAN)

Go Back to All Clinical Trials

VEDOKIDS study: Predicting response to Vedolizumab in Pediatric Inflammatory Bowel Diseases including drug levels: a multi-center prospective Pan- European cohort study (P-ECCO and ESPGHAN)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Irritable Bowel Disease
Chrons Disease
Age: Between 0 Year(s) - 18 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Subjects diagnosed with Crohn's disease, Inflammatory Bowel Disease unclassified or Ulcerative Colitis
2. Subjects commenced on Vedolizumab(VDZ) for any reason (but not to prevent post –operative recurrence) and combined with any medications at any stage of the disease

You may not be eligible for this study if the following are true:

1. Subjects who are pregnant
2. Subjects who are on Vedolizumab(VDZ) to prevent post –operative recurrence

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies